imatinib has been researched along with 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, NS; Liu, Y | 1 |
1 other study(ies) available for imatinib and 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea
| Article | Year |
|---|---|
Rational design of inhibitors that bind to inactive kinase conformations.
Topics: Binding Sites; Drug Design; Humans; Models, Molecular; Phosphotransferases; Protein Kinase Inhibitors; Protein Structure, Tertiary | 2006 |